By Alexander Zaitsev In NewsPosted July 6, 2023 MGH FTD Unit applauds FDA approval of lecanemab The U.S. Food and Drug Administration converted Leqembi (lecanemab), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a [...] 0 Read More
